# SU5416 in Patients With AIDS-Related Kaposi's Sarcoma Who Have Not Responded to Treatment

> **NCT00005931** · PHASE2 · COMPLETED · sponsor: **SUGEN** · enrollment: 30 (—)

## Conditions studied

- Sarcoma, Kaposi
- HIV Infections

## Interventions

- **DRUG:** SU5416

## Key facts

- **NCT ID:** NCT00005931
- **Lead sponsor:** SUGEN
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 30 (—)
- **Last updated:** 2005-06-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00005931

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00005931, "SU5416 in Patients With AIDS-Related Kaposi's Sarcoma Who Have Not Responded to Treatment". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00005931. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*